159 related articles for article (PubMed ID: 32798595)
21. Deintensification candidate subgroups in human papillomavirus-related oropharyngeal cancer according to minimal risk of distant metastasis.
O'Sullivan B; Huang SH; Siu LL; Waldron J; Zhao H; Perez-Ordonez B; Weinreb I; Kim J; Ringash J; Bayley A; Dawson LA; Hope A; Cho J; Irish J; Gilbert R; Gullane P; Hui A; Liu FF; Chen E; Xu W
J Clin Oncol; 2013 Feb; 31(5):543-50. PubMed ID: 23295795
[TBL] [Abstract][Full Text] [Related]
22. Comparisons of dysphagia and quality of life (QOL) in comparable patients with HPV-positive oropharyngeal cancer receiving chemo-irradiation or cetuximab-irradiation.
Samuels SE; Tao Y; Lyden T; Haxer M; Spector M; Malloy KM; Prince ME; Bradford CR; Worden FP; Schipper M; Eisbruch A
Oral Oncol; 2016 Mar; 54():68-74. PubMed ID: 26776757
[TBL] [Abstract][Full Text] [Related]
23. Radiotherapy versus Surgery in Early-Stage HPV-Positive Oropharyngeal Cancer.
Kim DY; Wu HG; Kim JH; Lee JH; Ahn SH; Chung EJ; Eom KY; Jung YH; Jeong WJ; Kwon TK; Kim S; Wee CW
Cancer Res Treat; 2022 Apr; 54(2):406-416. PubMed ID: 34176249
[TBL] [Abstract][Full Text] [Related]
24. Mature results of a prospective study of deintensified chemoradiotherapy for low-risk human papillomavirus-associated oropharyngeal squamous cell carcinoma.
Chera BS; Amdur RJ; Tepper JE; Tan X; Weiss J; Grilley-Olson JE; Hayes DN; Zanation A; Hackman TG; Patel S; Sheets N; Weissler MC; Mendenhall WM
Cancer; 2018 Jun; 124(11):2347-2354. PubMed ID: 29579339
[TBL] [Abstract][Full Text] [Related]
25. Primary surgery for human papillomavirus-associated oropharyngeal cancer: Survival outcomes with or without adjuvant treatment.
Cramer JD; Ferris RL; Kim S; Duvvuri U
Oral Oncol; 2018 Dec; 87():170-176. PubMed ID: 30527235
[TBL] [Abstract][Full Text] [Related]
26. Determining optimal follow-up in the management of human papillomavirus-positive oropharyngeal cancer.
Frakes JM; Naghavi AO; Demetriou SK; Strom TJ; Russell JS; Kish JA; McCaffrey JC; Otto KJ; Padhya TA; Harrison LB; Trotti AM; Caudell JJ
Cancer; 2016 Feb; 122(4):634-41. PubMed ID: 26565997
[TBL] [Abstract][Full Text] [Related]
27. Comparison of Survival of Patients With T
Zeng X; Peng L; Wen W; Sun W
Laryngoscope; 2022 Jun; 132(6):1205-1212. PubMed ID: 34797566
[TBL] [Abstract][Full Text] [Related]
28. Matted nodes: High distant-metastasis risk and a potential indication for intensification of systemic therapy in human papillomavirus-related oropharyngeal cancer.
Vainshtein JM; Spector ME; Ibrahim M; Bradford CR; Wolf GT; Stenmark MH; Worden FP; McHugh JB; Prince ME; Carey T; Chepeha DB; Eisbruch A
Head Neck; 2016 Apr; 38 Suppl 1(Suppl 1):E805-14. PubMed ID: 25914344
[TBL] [Abstract][Full Text] [Related]
29. Early
Mowery YM; Vergalasova I; Rushing CN; Choudhury KR; Niedzwiecki D; Wu Q; Yoo DS; Das S; Wong TZ; Brizel DM
Int J Radiat Oncol Biol Phys; 2020 Nov; 108(4):969-976. PubMed ID: 32800802
[TBL] [Abstract][Full Text] [Related]
30. Human papillomavirus oropharynx carcinoma: Aggressive de-escalation of adjuvant therapy.
Moore EJ; Van Abel KM; Routman DM; Lohse CM; Price KAR; Neben-Wittich M; Chintakuntlawar AV; Price DL; Kasperbauer JL; Garcia JJ; Hinni ML; Patel SH; Janus JR; Foote RL; Ma DJ
Head Neck; 2021 Jan; 43(1):229-237. PubMed ID: 32969095
[TBL] [Abstract][Full Text] [Related]
31. Oncologic outcomes of selective neck dissection in HPV-related oropharyngeal squamous cell carcinoma.
Zenga J; Jackson RS; Graboyes EM; Sinha P; Lindberg M; Martin EJ; Ma D; Thorstad WL; Rich JT; Moore EJ; Haughey BH
Laryngoscope; 2017 Mar; 127(3):623-630. PubMed ID: 27634021
[TBL] [Abstract][Full Text] [Related]
32. Definitive tumor directed therapy confers a survival advantage for metachronous oligometastatic HPV-associated oropharyngeal cancer following trans-oral robotic surgery.
Wright CM; Lee DY; Shimunov D; Carmona R; Barsky AR; Sun L; Cohen RB; Bauml JM; Brody RM; Basu D; Rassekh CH; Chalian AA; Newman JG; Rajasekaran K; Weinstein GS; Lukens JN; Lin A; Swisher-McClure S
Oral Oncol; 2021 Oct; 121():105509. PubMed ID: 34474270
[TBL] [Abstract][Full Text] [Related]
33. Regional control is preserved after dose de-escalated radiotherapy to involved lymph nodes in HPV positive oropharyngeal cancer.
Woody NM; Koyfman SA; Xia P; Yu N; Shang Q; Adelstein DJ; Scharpf J; Burkey B; Nwizu T; Saxton J; Greskovich JF
Oral Oncol; 2016 Feb; 53():91-6. PubMed ID: 26711089
[TBL] [Abstract][Full Text] [Related]
34. Patterns of failure in high-metastatic node number human papillomavirus-positive oropharyngeal carcinoma.
Lee NCJ; Kelly JR; Park HS; An Y; Judson BL; Burtness BA; Husain ZA
Oral Oncol; 2018 Oct; 85():35-39. PubMed ID: 30220317
[TBL] [Abstract][Full Text] [Related]
35. Risk and response adapted de-intensified treatment for HPV-associated oropharyngeal cancer: Optima paradigm expanded experience.
Rosenberg AJ; Agrawal N; Pearson A; Gooi Z; Blair E; Cursio J; Juloori A; Ginat D; Howard A; Chin J; Kochanny S; Foster C; Cipriani N; Lingen M; Izumchenko E; Seiwert TY; Haraf D; Vokes EE
Oral Oncol; 2021 Nov; 122():105566. PubMed ID: 34662771
[TBL] [Abstract][Full Text] [Related]
36. The prognostic value of extranodal extension in human papillomavirus-associated oropharyngeal squamous cell carcinoma.
An Y; Park HS; Kelly JR; Stahl JM; Yarbrough WG; Burtness BA; Contessa JN; Decker RH; Koshy M; Husain ZA
Cancer; 2017 Jul; 123(14):2762-2772. PubMed ID: 28323338
[TBL] [Abstract][Full Text] [Related]
37. Retropharyngeal lymph node involvement in human papillomavirus-associated oropharyngeal squamous cell carcinoma.
Baxter M; Chan JY; Mydlarz WK; Labruzzo SV; Kiess A; Ha PK; Aygun N; Agrawal N
Laryngoscope; 2015 Nov; 125(11):2503-8. PubMed ID: 26227748
[TBL] [Abstract][Full Text] [Related]
38. 12 week PET-CT has low positive predictive value for nodal residual disease in human papillomavirus-positive oropharyngeal cancers.
Rulach R; Zhou S; Hendry F; Stobo D; James A; Dempsey MF; Grose D; Lamb C; Schipani S; Rizwanullah M; Wilson C; Paterson C
Oral Oncol; 2019 Oct; 97():76-81. PubMed ID: 31437587
[TBL] [Abstract][Full Text] [Related]
39. Novel imaging classification system of nodal disease in human papillomavirus-mediated oropharyngeal squamous cell carcinoma prognostic of patient outcomes.
Sabiq F; Huang K; Patel A; Banerjee R; Debenham B; Lau H; Skarsgard D; Chen G; Lysack JT; Quon HC
Head Neck; 2021 Jun; 43(6):1854-1863. PubMed ID: 33638232
[TBL] [Abstract][Full Text] [Related]
40. Impact of cisplatin dose intensity on human papillomavirus-related and -unrelated locally advanced head and neck squamous cell carcinoma.
Spreafico A; Huang SH; Xu W; Granata R; Liu CS; Waldron JN; Chen E; Ringash J; Bayley A; Chan KK; Hope AJ; Cho J; Razak AA; Hansen A; Jang R; Perez-Ordonez B; Weinreb I; Bossi P; Orlandi E; Licitra LF; Song Y; O'Sullivan B; Siu LL; Kim J
Eur J Cancer; 2016 Nov; 67():174-182. PubMed ID: 27669504
[TBL] [Abstract][Full Text] [Related]
[Previous] [Next] [New Search]
